报告时间：2017年10月19日14:00-15:30 报告地点：玉泉校区教三338 题目: Multimodality Imaging-Guided Cancer Phototherapy 摘要： Nanotheranostics, combining both diagnostic and therapeutic functions into nanoscale agents, is an emerging interdiscipline that is paving the
报告时间：2017年10月19日14:00-15:30
报告地点：玉泉校区教三338
题目: Multimodality Imaging-Guided Cancer Phototherapy
摘要： Nanotheranostics, combining both diagnostic and therapeutic functions into nanoscale agents, is an emerging interdiscipline that is paving the avenue towards the goal of personalized medicine. For diagnosis, multimodal imaging is promising to furnish complementary information, such as anatomic, physiologic, molecular, and genomic information, for accurate diagnosis, monitoring therapy response, guiding drug discovery/development, and so on. For cancer therpay, photothermal therapy (PTT) that employs photothermal conversion agents (PTCAs) to “cook” cancer tissues and cells upon laser irradiation has been increasingly recognized as a promising alternative to the conventional approaches for cancer treatment. In the past few years, we have developed a series of nanotheranostics that have shown excellent imaging and high efficacy of cancer phototherapy in animal experiments. This talk will highlight our recent advances in using nanoplatforms for in vivo multimodality imaging-guided cancer phototherapy. Some issues of nanotheranostics in clinical translation will also be discussed.
简介：
黄鹏，博士，深圳大学医学部全职特聘教授。2012年获上海交通大学博士学位，2012-2015年在美国国立卫生研究院（NIH）做博士后，2015年底回深圳大学工作。入选中央组织部“青年千人计划”，深圳市海外高层次人才（孔雀计划B类）。主要学术兼职：美印联合基金评审专家、国家自然科学基金通信评审专家等等。担任Advanced Materials，Journal of the American Chemical Society，ACS Nano，Theranostics，Biomaterials等四十多种国际顶级期刊审稿人。受邀担任Current Pharmaceutical Biotechnology杂志编委和Current Medicinal Chemistry的Thematic Issue主编，并担任Bentham Science出版社在中国的“Bentham Ambassador”。研究兴趣主要围绕疾病智能诊疗。
迄今发表SCI论文100多篇，在过去五年（2012-现在），以第一/同等贡献或通讯作者身份在国际重要学术期刊发表SCI论文35篇（其中IF > 10的18篇，IF 7-10的14篇），包括6篇Advanced Materials，2篇Angewandte Chemie International Edition，1篇Journal of the American Chemical Society，7篇ACS Nano，1篇Advanced Drug Delivery Reviews和1篇Chemical Society Reviews，12篇入选1%ESI高引论文（其中2篇为0.1%ESI），6篇封面文章，多篇被Nature Photonics等选为研究亮点，论文总引用超过5500次，H因子41。
